Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAukett Swanke Regulatory News (AUK)

Share Price Information for Aukett Swanke (AUK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.45
Bid: 1.30
Ask: 1.60
Change: 0.00 (0.00%)
Spread: 0.30 (23.077%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.45
AUK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

26 Mar 2020 07:00

RNS Number : 6072H
Aukett Swanke Group PLC
26 March 2020
 

Embargoed for release until 0700 26 March 2020

Aukett Swanke Group Plc

AGM statement

At the Company's Annual General Meeting to be held today at 12pm, Nicholas Thompson (CEO) will make the following statement:

Following the spread of the Covid-19 virus the Company and its subsidiaries, joint ventures and Associates implemented their Business Continuity Plans in line with local procedures and relevant government protocols.

Primarily this involved a transfer of office operations to home or remote working. Trialling of home working had been on-going and, due to the uneven spread of the virus some geographies were able to manage this shift in working arrangements in advance of others. Our three largest offices in London, Berlin and Dubai are now fully set up for remote working with only limited staff present in offices in line with local protocols.

Our services are spread across three different activities: concept and pre planning; technical drawings up to tender; and site services and inspections. The first two activities have been largely unaffected by this transition at present. The feasibility of work on site needs to be addressed on a case by case basis to ensure operational capacity, though practical issues can be partially mitigated by off-site reporting and communication. With most sites currently open and, social distancing in place, construction projects continue in most jurisdictions. We are monitoring this activity on a daily basis.

The cost impact of these changes has, thus far, been minimal in terms of additional direct capital expenditure though it remains to be seen as to the efficiency with which we are still able to deliver services and the impact this may have. The Board will continue to monitor all aspects of customer service delivery and take whatever mitigating actions as are required.

The company operates a stringent cash management system across all operations and thus Group liquidity is good at this time; we expect to be able to continue to operate within current banking facilities. UK state support schemes are being looked into as a matter of urgency and will be implemented shortly, as required.

Clearly no business is immune to the wider effects of a pandemic but so far Aukett continues to function well and is as focussed as ever on supporting all stakeholders alike, customers, employees and suppliers.

We are grateful to our staff for their perseverance in maintaining client services whilst observing and following guidance on their self-protection and personal well-being.

Enquiries

 

Aukett Swanke Group Plc - 020 7843 3000

Nicholas Thompson, Chief Executive Officer

Antony Barkwith, Group Finance Director

 

finnCap - 020 7220 0500

Corporate Finance: Julian Blunt; Giles Rolls / Corporate Broking: Alice Lane

 

Investor/Media enquiries

 

Chris Steele 07979 604 687

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMKKPBNPBKDFNB
Date   Source Headline
5th Mar 20144:37 pmRNSHolding(s) in Company
3rd Mar 20145:20 pmRNSDirector/PDMR Shareholding
25th Feb 20149:13 amRNSAnnual Financial Report
20th Jan 20147:00 amRNSAnnual Financial Report
15th Jan 20149:29 amRNSTotal Voting Rights
19th Dec 20137:00 amRNSAcquisition of Swanke Hayden Connell Europe Ltd
10th Dec 20137:00 amRNSDirectorate Change
2nd Dec 20137:00 amRNSTrading Update
8th Nov 20137:00 amRNSDividend Declaration
1st Oct 20137:00 amRNSTrading Update
12th Aug 20137:00 amRNSTrading Statement
7th Jun 20137:00 amRNSHalf Yearly Report
25th Mar 20132:45 pmRNSResult of AGM
13th Mar 201310:22 amRNSLitigation and Trading Update
27th Feb 20132:52 pmRNSAnnual Financial Report
30th Jan 20137:00 amRNSFinal Results
19th Jul 20123:08 pmRNSHalf Yearly Report
27th Jun 201211:31 amRNSDirector/PDMR Shareholding
7th Jun 20127:00 amRNSHalf Yearly Report
31st May 20127:00 amRNSNotice of Interim Results
27th Mar 20125:53 pmRNSResult of AGM and change of directorate
15th Feb 201212:06 pmRNSAnnual Financial Report
12th Jan 20127:00 amRNSFinal Results
18th Oct 20118:27 amRNSDirector/PDMR Shareholding
20th Sep 20117:00 amRNSTrading update
1st Jul 20117:00 amRNSLitigation update
21st Jun 20117:00 amRNSHalf Yearly Report
12th Apr 20119:26 amRNSDirector/PDMR Shareholding
7th Apr 201111:21 amRNSTrading update
31st Mar 201112:55 pmRNSResult of AGM
25th Feb 20119:37 amRNSAnnual Financial Report
2nd Feb 20117:00 amRNSFinal Results
15th Nov 20102:37 pmRNSDirectorate Change
8th Oct 20107:00 amRNSTrading Update
17th Jun 20107:00 amRNSHalf Yearly Report
21st May 20107:00 amRNSNew contract
17th May 20107:00 amRNSTrading Statement
4th May 201012:34 pmRNSHolding(s) in Company
25th Mar 201010:20 amRNSResult of AGM
17th Mar 201011:22 amRNSDirector/PDMR Shareholding
24th Feb 20107:00 amRNSAnnual Financial Report
14th Jan 20107:00 amRNSFinal Results
21st Jul 20098:00 amRNSTrading Statement
8th Jul 20094:35 pmRNSFurther re recovery litigation
1st Jul 20097:00 amRNSDirectorate Change
18th Jun 20097:00 amRNSHalf Yearly Report
1st Jun 20098:41 amRNSChange of Registered Office
24th Apr 200911:04 amRNSTrading Statement
3rd Apr 20097:00 amRNSDirectorate Change
26th Mar 200910:53 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.